表紙
市場調查報告書

生物標記:發現技術和應用 - 全球市場概要

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

出版商 Industry Experts 商品編碼 906609
出版日期 內容資訊 英文 410 Pages, 149 Charts
訂單完成後即時交付
價格
Back to Top
生物標記:發現技術和應用 - 全球市場概要 Biomarkers: Discovery Techniques and Applications - A Global Market Overview
出版日期: 2019年08月14日內容資訊: 英文 410 Pages, 149 Charts
簡介

生物標記市場預計至2021年達到約500億美元的規模。各應用領域中癌症佔主導地位,2018年的市場佔有率構成41.2%,2019年預計達到156億美元的規模。

本報告提供全球生物標記市場相關調查分析,世界、地區市場分析與預測,主要企業等相關的系統性資訊。

A部分:全球市場預測

第1章 簡介

第2章 主要市場趨勢

第3章 主要世界的企業

  • Abbott Diagnostics (美國)
  • Agendia NV (荷蘭)
  • Agilent Technologies, Inc. (美國)
  • Asuragen, Inc. (美國)
  • Beckman Coulter, Inc. (美國)
  • Biocartis NV (比利時)
  • bioMerieux SA (法國)
  • Bio-Rad Laboratories, Inc. (美國)
  • Bruker Corporation (美國)
  • Caprion Biosciences, Inc. (加拿大)
  • Charles River Laboratories, Inc. (美國)
  • Cisbio Bioassays (法國)
  • EKF Diagnostics Holdings Plc (英國)
  • Enzo Biochem, Inc. (美國)
  • Epigenomics AG (德國)
  • F. Hoffmann-La Roche AG (瑞士)
  • GE Healthcare (美國)
  • Genedata AG (瑞士)
  • Genomic Health, Inc. (美國)
  • Human Metabolome Technologies (日本)
  • Illumina, Inc. (美國)
  • Janssen Pharmaceutica NV (比利時)
  • Koninklijke Philips N.V (荷蘭)
  • Meso Scale Diagnostics LLC. (美國)
  • Metabolon, Inc. (美國)
  • MilliporeSigma (美國)
  • Myriad Genetics, Inc. (美國)
  • NanoString Technologies, Inc. (美國)
  • Nexus Dx (美國)
  • PerkinElmer, Inc. (美國)
  • Pharmaceutical Product Development LLC (美國)
  • QIAGEN B.V. (荷蘭)
  • Rosetta Genomics (以色列)
  • Siemens Healthineers (德國)
  • Singulex, Inc. (美國)
  • Thermo Fisher Scientific, Inc.(美國)
  • Waters Corporation (美國)

第4章 主要商務、產品趨勢

第5章 全球市場概要

  • 各發現
  • 各治療領域

B部分:地區市場預測

地區市場概要

第6章 北美

  • 各地區
  • 各發現
  • 各治療領域
  • 主要企業
  • 各國
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲

  • 各地區
  • 各發現
  • 各治療領域
  • 主要企業
  • 各國
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 其他

第8章 亞太地區

  • 各地區
  • 各發現
  • 各治療領域
  • 主要企業
  • 各國
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他

第9章 其他地區

  • 各發現
  • 各治療領域
  • 主要企業

C部分:產業指南

D部分:附錄

目錄
Product Code: BT006

Report Synopsis

The factors driving the Biomarkers market growth includes elevated demand for personalized medicine, technological advancement, immense utilization of biomarkers in drug discovery and development procedures, massive research on biomarkers, increasing awareness about role of biomarkers in early disease diagnosis, increase research funding, and many more.

Global market for Biomarkers is dominated by Oncology, in terms of application, estimated at a market share of 41.2% in 2018 and forecast to touch US$15.6 billion in 2019.The overall market for Biomarkers is projected to reach approximately US$50 billion by 2021.

Research Findings &Coverage

  • Worldwide market for Biomarkers is analyzed in thisreport with respect to discovery technologies and therapeutic areas/applications
  • Biomarkers'market size is reportedin this study bybiomarker discovery technologies, therapeutic/applications areas across all major countries
  • Biomarkers Detection by Glycan Antibody Technique
  • Role of Proteomic Techniques in Discovering Gingival Crevicular Fluid Biomarkers
  • Combination of sTRA and CA19-9 Test to Detect Pancreatic Cancer Biomarkers
  • Discovery of Novel Imaging Biomarker for Coronary Inflammation
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 51
  • The industry guide includes the contact details for 225 companies

Product Outline

The report analyzes the market for the following key discovery technologies of Biomarkers:

  • Omics Technologies
    • Proteomics
    • Genomics
    • Metabolomics
    • Other
  • Bioimaging
    • MRI
    • CT
    • Ultrasound
    • Other
  • Bioinformatics

The market for major applications of Biomarkersexplored in this report comprise the following:

  • Oncology
  • Cardiology
  • Neurology
  • Other

Analysis Period, Units and Growth Rates

The report reviews, analyzes and projects the globalBiomarkersmarket for the period 2016-2025 in terms ofmarket value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025.

Geographic Coverage

  • North America (United States, Canada and Mexico)
  • Europe (Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe)
  • Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific)
  • Rest of World

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. Biomarkers Defined
    • 1.1.2. Biomarkers in Medicine
      • 1.1.2.1. A History of Biomarkers
        • 1.1.2.1.1. Philadelphia Chromosome
        • 1.1.2.1.2. HIV Viral Load
        • 1.1.2.1.3. HER-2 Gene and Receptor
      • 1.1.2.2. Biomarkers for Diseases and Biomarkers for Drugs
      • 1.1.2.3. Prerequisites of Biomarkers
      • 1.1.2.4. Categorization of Biomarkers
        • 1.1.2.4.1. Categorization of Biomarkers based on Types
      • 1.1.2.5. Biomarkers in Drug Development
      • 1.1.2.6. Biomarkers in Diseases
    • 1.1.3. Biomarkers Discovery Technologies
      • 1.1.3.1. Omics Technologies
        • 1.1.3.1.1. Proteomic Methods of Biomarkers Discovery
          • 1.1.3.1.1.1. 2D-PAGE (Two-Dimensional Gel Electrophoresis)
          • 1.1.3.1.1.2. LC-MS (Liquid Chromatography Mass Spectrometer)
          • 1.1.3.1.1.3. SELDI-TOF (Surface-Enhanced Laser Desorption/Ionization)
          • 1.1.3.1.1.4. Immunohistochemistry
          • 1.1.3.1.1.5. Antibody (Ab) Microarray
          • 1.1.3.1.1.6. Tissue Microarray
        • 1.1.3.1.2. Genomic Methods of Biomarkers Discovery
          • 1.1.3.1.2.1. Northern Blot
          • 1.1.3.1.2.2. Polymerase Chain Reaction (PCR)
            • 1.1.3.1.2.2.1. Real Time PCR
          • 1.1.3.1.2.3. Gene Expression
          • 1.1.3.1.2.4. Serial Analysis of Gene Expression (SAGE)
          • 1.1.3.1.2.5. DNA Microarray
        • 1.1.3.1.3. Metabolomics Methods of Biomarkers Discovery
        • 1.1.3.1.4. Other Omics Technologies for Biomarkers Discovery
          • 1.1.3.1.4.1. Lipidomics
          • 1.1.3.1.4.2. Glycomics
          • 1.1.3.1.4.3. Secretomics
            • 1.1.3.1.4.3.1. Application of Secretomics in Discovery of Cancer Biomarkers
            • 1.1.3.1.4.3.2. Application of Secretomics in Assisted Reproductive Technologies
      • 1.1.3.2. Imaging Technologies
        • 1.1.3.2.1. Magnetic Resonance Imaging (MRI)
        • 1.1.3.2.2. Computed Tomography (CT)
        • 1.1.3.2.3. Ultrasound (US)
        • 1.1.3.2.4. X-Rays
        • 1.1.3.2.5. Positron Emission Tomography (PET)
        • 1.1.3.2.6. Single Photon Emission Computed Tomography (SPECT)
        • 1.1.3.2.7. Others
      • 1.1.3.3. Bioinformatics
    • 1.1.4. Therapeutic Areas for Biomarkers
      • 1.1.4.1. Cancer Biomarkers
        • 1.1.4.1.1. Cancer Biomarkers Defined
        • 1.1.4.1.2. Functions of Biomarkers in Cancer Medicine
          • 1.1.4.1.2.1. Evaluation of Risk
          • 1.1.4.1.2.2. Diagnosis
          • 1.1.4.1.2.3. Prognosis and Prediction of Therapy
          • 1.1.4.1.2.4. Pharmacodynamics and Pharmacokinetics
          • 1.1.4.1.2.5. Therapy Response Monitoring
          • 1.1.4.1.2.6. Predicting or Monitoring Recurrence of Cancer
        • 1.1.4.1.3. Functions of Biomarkers in Cancer Research
          • 1.1.4.1.3.1. Drug Target Discovery and Development
          • 1.1.4.1.3.2. Surrogate Endpoints
        • 1.1.4.1.4. Categories of Cancer Markers
      • 1.1.4.2. Cardiac Biomarkers
        • 1.1.4.2.1. Measurement Applications of Cardiac Biomarkers
        • 1.1.4.2.2. Classes of Cardiac Marker Tests
          • 1.1.4.2.2.1. Shortcomings of Cardiac Marker Tests
        • 1.1.4.2.3. Biomarkers of Coronary Artery Disease
        • 1.1.4.2.4. Role Played by Innovative Multiple Biomarkers in Predicting Cardiovascular Outcomes
      • 1.1.4.3. Biomarkers for Neurological Disorders
      • 1.1.4.4. Other Therapeutic Areas for Biomarkers
        • 1.1.4.4.1. Biomarkers of Diabetes
        • 1.1.4.4.2. Biomarkers of Aging

2. KEY MARKET TRENDS

  • 2.1. Biomarkers Detection by Glycan Antibody Technique
  • 2.2. Role of Proteomic Techniques in Discovering Gingival Crevicular Fluid Biomarkers Proteomic Technology (GC/MS, MALDI-TOF MS, and LC-MS/MS)
  • 2.3. Novel Biomarkers May Assist Rapid Diagnosis of Autism
  • 2.4. Detection of Autoimmune and Inflammatory Disorders Using Aberrant Non-Coding RNA
  • 2.5. Abnormal miRNA Expression Profiles of T Cells Acts as Biomarkers of Pathogenesis and Ailment in SLE Sufferers
  • 2.6. Combination of sTRA and CA19-9 Test to Detect Pancreatic Cancer Biomarkers
  • 2.7. Proteomics Application to Discover Serum Biomarkers of Kawasaki Disease
  • 2.8. Novel Rheumatoid Arthritis Biomarkers Detected by Researchers
  • 2.9. Discovery of New Kidney Cancer Biomarkers
  • 2.10. Correlation of Novel Inflammatory Biomarkers with Elevated Thrombosis Risk in Cancer Survivors
  • 2.11. Identification of Biomarker for Widespread Heart Failure Type
  • 2.12. Discovery of Novel Imaging Biomarker for Coronary Inflammation
  • 2.13. A Novel Biomarker Based Bioimaging Approach for Kidney Cancer Cell Assessment
  • 2.14. New Biomarker and Therapy for Melanoma has Been Discovered by BU Investigators
  • 2.15. microRNA Signature - A Novel Biomarker Discovered for Postoperative Liver Disorder

3. KEY GLOBAL PLAYERS

  • Abbott Diagnostics (United States)
  • Agendia NV (The Netherlands)
  • Agilent Technologies, Inc. (United States)
  • Asuragen, Inc. (United States)
  • Beckman Coulter, Inc. (United States)
  • Biocartis NV (Belgium)
  • bioMérieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Bruker Corporation (United States)
  • Caprion Biosciences, Inc. (Canada)
  • Charles River Laboratories, Inc. (United States)
  • Cisbio Bioassays (France)
  • EKF Diagnostics Holdings Plc (United Kingdom)
  • Enzo Biochem, Inc. (United States)
  • Epigenomics AG (Germany)
  • F. Hoffmann-La Roche AG (Switzerland)
  • GE Healthcare (United States)
  • Genedata AG (Switzerland)
  • Genomic Health, Inc. (United States)
  • Human Metabolome Technologies (Japan)
  • Illumina, Inc. (United States)
  • Janssen Pharmaceutica NV (Belgium)
  • Koninklijke Philips N.V (The Netherlands)
  • Meso Scale Diagnostics LLC. (United States)
  • Metabolon, Inc. (United States)
  • MilliporeSigma (United States)
  • Myriad Genetics, Inc. (United States)
  • NanoString Technologies, Inc. (United States)
  • Nexus Dx (United States)
  • PerkinElmer, Inc. (United States)
  • Pharmaceutical Product Development LLC (United States)
  • QIAGEN B.V. (The Netherlands)
  • Rosetta Genomics (Israel)
  • Siemens Healthineers (Germany)
  • Singulex, Inc. (United States)
  • Thermo Fisher Scientific, Inc.(United States)
  • Waters Corporation (United States)

4. KEY BUSINESS AND PRODUCT TRENDS

  • therascreen® PIK3CA RGQ PCR Kit, the First FDA-Cleared Companion Diagnostic Assay to detect 11 PIK3CA Gene Mutations
  • Establishment of APIS Assay Technologies Ltd. for Broadening Biomarker Research in Europe
  • Siemens Releases a Novel Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay for Diabetes
  • Development of New Ultra-High Field 18 Tesla MRI System by Bruker and Champalimaud
  • Development of Diagnostic Tool for Molecular Biomarker Detection by GE and Indi Molecular
  • Epigenomics' Application for Colorectal Cancer Screening Blood Test Accepted by Centers for Medicare & Medicaid Services for NCD review
  • Serametrix Corporation Acquired by Caprion Biosciences
  • US FDA Offers 510 (k) Clearance for Beckman Coulter's Early Sepsis Indicator
  • Agendia's New Innovation and R&D Excellence Center in the Netherlands
  • Abbott'sCore Laboratory Instruments to Employ Banyan's Traumatic Brain Injury Blood Biomarkers
  • Expansion of Bruker's MALDI Biotyper, IR Biotyper and Fluorocycler XT Product Portfolio
  • Cisbio Bioassays Acquired by PerkinElmer
  • Bio-Rad's IH-500 Blood Typing and Screening System Receives U.S. FDA Clearance
  • NanoString and Leica Biosystems Ink Deal to Market Products for High Throughput Spatial Analysis
  • New Immunoassay for Kratom Alkaloid Mitragynine Screening Introduced by Thermo Fisher Scientific
  • Bio-Techne and NanoString in Collaboration to Develop Integrated Workflow for RNA Spatial Profiling
  • Myriad Introduces Prequel™ Prenatal Screen with all 23 Chromosome Pairs
  • Caprion Biosciences Advances Biomarker Discovery and Immune Monitoring by Providing Mass Cytometry Services
  • EKF Diagnostics Inks Pact with McKesson to Distribute DiaSpect Tm Hemoglobin Analyzer in the United States
  • Grant of European Patent for Singulex High Sensitivity Methods to Quantify Cardiac Troponin
  • Genomic Health Develops IVD Version of Idylla™ Oncotype DX® GPS™ Test
  • Epigenomics Initiates Prospective Clinical Study for Liver Cancer Detection DNA Biomarkers
  • Pacific Biosciences to be Taken Over by Illumina to Speed-Up Scientific Discovery
  • bioMérieux Reinforces its Immunoassay Offerings by Acquiring Major Shares in Hybiome
  • BIOFIRE® FILMARRAY® Pneumonia Panels of bioMérieux Receives CE Mark and FDA Clearance
  • Siemens Introduces Magnetom Lumina (3 Tesla) and Magnetom Altea MRI Systems
  • USDA Contract Awarded for Bio-Rad' Pathogen Detection Testing Products
  • Epigenomics AG Receives CE Mark for Liquid Biopsy Test for Liver Cancer Detection
  • Myriad and Pfizer Inks Deal to Commercialize Myriad's BRACAnalysis CDx® as a Companion Diagnostic with Pfizer's Talazoparib
  • Healthy.io Join Forces with Siemens to Enhance Kidney Disease Monitorization
  • Introduction of TruSight Oncology 500 by Illumina for Pan Cancer Tumor Profiling
  • Setting up of High-field 9.4 Tesla Preclinical PET/MR System at German Cancer Research Center by Bruker
  • US Department of Defense Awards Contract to Procure Banyan Brain Trauma Indicator
  • Commercial Launch of Singulex Clarity C. diff Toxin A/B Assay
  • Agendia in Collaboration with Genecast Offers MammaPrint® and BluePrint® Tests in China for the First Time
  • Release of New Preclinical PET/CT Si78 Scanner by Bruker
  • Primity Bio Acquired by Caprion Biosciences
  • Three Low Cost Cancer Detecting Biomarkers from ENZO Biochem Successfully Validated
  • Launch of Shimadzu Q-TOF LCMS-9030 Mass Spectrometer
  • Introduction of Novel SKYSCAN 2214 Ultra-High Resolution Nano-CT by Bruker
  • Launch of ParaVision® 360 and AVANCE® NEO Systems by Bruker
  • NanoString Collaborated with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery
  • Thermo Fisher Scientific Opens Precision Medicine Science Center in The United States
  • MyriadGenetics to Acquire Counsyl
  • Thermo Fisher Scientific Inks Deal with Daiichi Sankyo and Takeda Pharmaceuticals to Expand Oncomine Dx Target Test
  • sphingotec to Offer penKid® and bio-ADM® Biomarkers on NEXUS IB 10 POC Testing Platform
  • Unicancer Chooses Agendia's MammaPrint® and BluePrint® Tests
  • Bio-Rad Introduces Bio-Plex Pro human Cytokine Screening Panel
  • EKF Wins FDA Clearance for DiaSpect Tm Hemoglobin Analyzer
  • Myriad's BRACAnalysis® Diagnostic System Receives Pre-Market Approval in Japan
  • NanoString to Market Digital Spatial Profiling Service through Leading Contract Research Organizations
  • NanoString Launches Breast Cancer 360 Research Panel
  • Shimadzu Launches UV-1900 UV-VIS Spectrophotometer
  • Agreement Signed by Illumina and Loxo to Co Develop NGS Based Pan Cancer Companion Diagnostics
  • Strengthening of bioMérieux's Immunoassay Biomarkers Portfolio by Acquiring Astute
  • Illumina and Bristol-Myers Squibb Collaborate to Develop and Market CDxs for Cancer Drugs
  • Release of Magnetom Sola and BioMatrix Technology by Siemens to Expand Personalized Medicine
  • Siemens Introduces a Novel Acuson Juniper Next-Generation Ultrasound System
  • Metabolon's Meta UDx™ Test is Now Available for Difficult-to-Diagnose Patient Cases
  • Launch of Shimadzu's Nexera Mikros Microflow Liquid Chromatography Mass Spectrometry System
  • Launch of Genedata Profiler® 11.0 Enterprise Software Platform for Omics-based Profiling of Patients
  • Banyan Biomarkers Receives FDA Grant for the Commercialization of the First IVD Blood Test for TBI
  • US FDA Approves Myriad's BRACAnalysis CDx® as Companion Diagnostic for Lynparza™(olaparib) In Patients with Metastatic Breast Cancer
  • Myriad Genetics Strengthens Research Collaboration with AstraZeneca
  • NanoString and RikenGenesis to Commercialize nCounter-Based Diagnostic Assays in Japan
  • AMPIPROBE® Women's Health Panel Launched by Enzo Clinical Labs
  • Collaborative NGS Technology Development Deal Signed by Illumina and KingMed
  • Fast Track Diagnostics Completely Taken Over by Siemens
  • Siemens Collaborates With Circle Cardiovascular to Improve Cardiac Imaging
  • Epigenomics Receives CE-IVD Mark for Lung Cancer Test Epi proLung®
  • Agendia Collaborates with Bluebee to Launch MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping Kit
  • sphingotec and Ortho Jointly Offer sphingotest® bio-ADM® Assay for Clinical Laboratories Globally
  • Agendia and Institute Curie Partners for the Co-validation Study of MammaPrint® BluePrint® Kit
  • sphingotec and Mayo Clinic Partner to Assess Four Biomarkers
  • EKF's Procalcitonin Assay Wins FDA Clearance and Validated for Beckman AU Chemistry Analyzers
  • Genomic Health Develops New Prostate Cancer Tests based on Cleveland Diagnostics' IsoPSA™Reagent and SIA Technology
  • Release of NextSeq™550Dx System by Illumina and Extends the Application of MiSeqTM Dx System
  • Ortho Clinical Diagnostics to Use EKF Diagnostics™Diabetic Ketoacidosis Assay
  • Thermo Fisher Scientific and Blueprint Medicines Ink Deal for Oncology Companion Diagnostic Development
  • Expansion of laboratory Hematology Solutions by Siemens and HORIBA
  • Grant of Patent for Singulex Methods to Digitally Detect Single Molecules of Cardiac Troponin
  • Scientific Collaboration of Caprion Biosciences with the FNIK Biomarkers Consortium
  • sphingotec Collaborates with Shuwen for Biomarkers Marketing in China
  • Publication of a New Blood Protein Study for Predictive Tuberculosis Infection Using ProteoCarta™Biomarker Panel
  • VITEK® MS of bioMérieux Receives FDA Approval for Extended Pathogen Detection
  • US FDA Clearance for Bio-Rad's BioPlex 2200 Syphilis Total & RPR Assay Testing Method
  • Thermo Fisher's Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies Approved by FDA
  • BioFire's FilmArray® Respiratory Panel 2 of boMérieux Obtains FDA Authorization
  • Extended RAS Panel of Illumina Receives FDA Approval
  • CE Mark for Singulex'First Ultrasensitive Cardiac Troponin Assay Powered by Single Molecule Counting Technology
  • EKF to Distribute Procalcitonin LiquiColor® Test into Eastern Europe, Middle East and APAC
  • sphingotec and bestbion dx Form Acute Care Biomarkers Marketing Pact
  • Joint collaboration of Metabolon and ADLQ to Set up Metabolomics Platform in Qatar
  • Myriad Genetics and BeiGene to Develop Companion Diagnostics for BeiGene's BGB-290 PARP Inhibitor
  • European Release of VeriSeq™ NIPT Solution by Illumina
  • BacT/ALERT® VIRTUO Blood Culture System of bioMérieux Gains FDA 510(k) Approval
  • bioMérieux Receives CE Approval for FilmArray® Respiratory Panel 2 plus
  • European CE Mark for Singulex' Sgx Clarity® System
  • Expansion of Clinical Assessment of Singulex Sgx Clarity™ System at European Research Sites
  • New V-PLEX® Assays for Th17 Research Introduced by Meso Scale Discovery
  • VIDAS® B.R.A.H.M.S PCT™ of bioMérieux Receives FDA Approval for Respiratory Infection and Sepsis
  • Metaérolon partners with Dian to Establish Discovery HD4™ Platform in China
  • bioMérieux inks Deal with Banyan Biomarkers for Development and Commercialization of Blood- Based Biomarkers for TBI
  • Singulex and QIAGEN Partnersfor Companion DiagnosticsDevelopment
  • Commercial Release of Vectra® Polaris™ Pathology Imaging System by PerkinElmer
  • Illumina Signs Integrated Genomics Solutions Deal with Philips

5. GLOBAL MARKET OVERVIEW

  • 5.1. Global Biomarkers Market Overview by Discovery Technology
    • 5.1.1. Global Omics Technologies for Biomarkers Market Overview by Segment
      • 5.1.1.1. Omics Technology Segments Market Overview by Global Region
        • 5.1.1.1.1. Proteomics
        • 5.1.1.1.2. Genomics
        • 5.1.1.1.3. Metabolomics
        • 5.1.1.1.4. Other Omics Technologies
    • 5.1.2. Global Bioimaging Market Overview by Modality
      • 5.1.2.1. Bioimaging Modalities Market Overview by Global Region
        • 5.1.2.1.1. MRI
        • 5.1.2.1.2. CT
        • 5.1.2.1.3. Ultrasound
        • 5.1.2.1.4. Other Bioimaging Modalities
    • 5.1.3. Biomarkers Discovery Technology Market Overview by Global Region
      • 5.1.3.1. Omics Technologies
      • 5.1.3.2. Bioimaging
      • 5.1.3.3. Bioinformatics
  • 5.2. Global Biomarkers Market Overview by Therapeutic Area
    • 5.2.1. Biomarkers Therapeutic Area Market Overview by Global Region
      • 5.2.1.1. Oncology
      • 5.2.1.2. Cardiology
      • 5.2.1.3. Neurology
      • 5.2.1.4. Other Therapeutic Areas

PART B: REGIONAL MARKET PERSPECTIVE

  • REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • 6.1. North American Biomarkers Market Overview by Geographic Region
  • 6.2. North American Biomarkers Market Overview by Discovery Technology
    • 6.2.1. North American Omics Technologies Market Overview by Segment
    • 6.2.2. North American Bioimaging Market Overview by Modality
    • 6.2.3. Biomarkers Discovery Technology Market Overview by NA Region
      • 6.2.3.1. Omics Technologies
      • 6.2.3.2. Bioimaging
      • 6.2.3.3. Bioinformatics
  • 6.3. North American Biomarkers Market Overview by Therapeutic Area
  • 6.4. Major Market Players
    • Abbott Diagnostics (United States)
    • Agilent Technologies, Inc. (United States)
    • Altheadx, Inc. (United States)
    • Asuragen, Inc. (United States)
    • Banyan Biomarkers, Inc. (United States)
    • Beckman Coulter, Inc. (United States)
    • BG Medicine, Inc. (United States)
    • Bio-Rad Laboratories, Inc. (United States)
    • Bruker Corporation (United States)
    • Caprion Biosciences, Inc. (Canada)
    • Charles River Laboratories, Inc. (United States)
    • ENZO Biochem, Inc. (United States)
    • GE Healthcare (United States)
    • Genomic Health, Inc. (United States)
    • Illumina, Inc. (United States)
    • Life Diagnostics, Inc. (United States)
    • Lifesign LLC. (United States)
    • Meso Scale Diagnostics LLC. (United States)
    • Metabolon, Inc. (United States)
    • Milliporesigma (United States)
    • Myriad Genetics, Inc. (United States)
    • Myriad RBM (United States)
    • Nanostring Technologies, Inc. (United States)
    • Nexus DX (United States)
    • Perkinelmer, Inc. (United States)
    • Pharmaceutical Product Development LLC (United States)
    • Shimadzu Scientific Instruments (United States)
    • Signosis, Inc. (United States)
    • Singulex, Inc. (United States)
    • Stagezero Life Sciences, Inc. (Canada)
    • Thermo Fisher Scientific, Inc. (United States)
    • Waters Corporation (United States)
  • 6.5. Country-wise Analysis of North American Biomarkers Market
    • 6.5.1. The United States
      • 6.5.1.1. United States Biomarkers Market Overview by Discovery Technology
    • 6.5.2. Canada
      • 6.5.2.1. Canadian Biomarkers Market Overview by Discovery Technology
    • 6.5.3. Mexico
      • 6.5.3.1. Mexican Biomarkers Market Overview by Discovery Technology

7. EUROPE

  • 7.1. European Biomarkers Market Overview by Geographic Region
  • 7.2. European Biomarkers Market Overview by Discovery Technology
    • 7.2.1. European Omics Technologies Market Overview by Segment
    • 7.2.2. European Bioimaging Market Overview by Modality
    • 7.2.3. Biomarkers Discovery Technology Market Overview by European Region
      • 7.2.3.1. Omics Technologies
      • 7.2.3.2. Bioimaging
      • 7.2.3.3. Bioinformatics
  • 7.3. European Biomarkers Market Overview by Therapeutic Area
  • 7.4. Major Market Players
    • Agendia Nv (The Netherlands)
    • Akuru Pharma AB (Sweden)
    • Bayer Pharma AG (Germany)
    • Biocartis NV (Belgium)
    • Biomérieux SA (France)
    • Biosystems International Kft (Hungary)
    • Cisbio Bioassays (France)
    • Decode Genetics (Iceland)
    • EKF Diagnostics Holdings Plc (United Kingdom)
    • Epigenomics AG (Germany)
    • F. Hoffmann-La Roche AG (Switzerland)
    • Genedata AG (Switzerland)
    • Janssen Pharmaceutica NV (Belgium)
    • Koninklijke Philips N.V (The Netherlands)
    • Pamgene International B.V. (The Netherlands)
    • Qiagen B.V. (The Netherlands)
    • Siemens Healthineers (Germany)
  • 7.5. Country-wise Analysis of European Biomarkers Market
    • 7.5.1. Germany
      • 7.5.1.1. German Biomarkers Market Overview by Discovery Technology
    • 7.5.2. The United Kingdom
      • 7.5.2.1. United Kingdom Biomarkers Market Overview by Discovery Technology
    • 7.5.3. France
      • 7.5.3.1. French Biomarkers Market Overview by Discovery Technology
    • 7.5.4. Italy
      • 7.5.4.1. Italian Biomarkers Market Overview by Discovery Technology
    • 7.5.5. Spain
      • 7.5.5.1. Spanish Biomarkers Market Overview by Discovery Technology
    • 7.5.6. Sweden
      • 7.5.6.1. Swedish Biomarkers Market Overview by Discovery Technology
    • 7.5.7. Rest of Europe
      • 7.5.7.1. Rest of Europe Biomarkers Market Overview by Discovery Technology

8. ASIA-PACIFIC

  • 8.1. Asia-Pacific Biomarkers Market Overview by Geographic Region
  • 8.2. Asia-Pacific Biomarkers Market Overview by Discovery Technology
    • 8.2.1. Asia-Pacific Omics Technologies Market Overview by Segment
    • 8.2.2. Asia-Pacific Bioimaging Market Overview by Modality
    • 8.2.3. Biomarkers Discovery Technology Market Overview by Asia-Pacific Region
      • 8.2.3.1. Omics Technologies
      • 8.2.3.2. Bioimaging
      • 8.2.3.3. Bioinformatics
  • 8.3. Asia-Pacific Biomarkers Market Overview by Therapeutic Area
  • 8.4. Human Metabolome Technologies (Japan) - A Major Market Player
  • 8.5. Country-wise Analysis of Asia-Pacific Biomarkers Market
    • 8.5.1. China
      • 8.5.1.1. Chinese Biomarkers Market Overview by Discovery Technology
    • 8.5.2. Japan
      • 8.5.2.1. Japanese Biomarkers Market Overview by Discovery Technology
    • 8.5.3. India
      • 8.5.3.1. Indian Biomarkers Market Overview by Discovery Technology
    • 8.5.4. Australia
      • 8.5.4.1. Australian Biomarkers Market Overview by Discovery Technology
    • 8.5.5. Rest of Asia-Pacific
      • 8.5.5.1. Rest of Asia-Pacific Biomarkers Market Overview by Discovery Technology

9. REST OF WORLD

  • 9.1. Rest of World Biomarkers Market Overview by Discovery Technology
    • 9.1.1. Rest of World Omics Technologies Market Overview by Segment
    • 9.1.2. Rest of World Bioimaging Market Overview by Modality
  • 9.2. Rest of World Biomarkers Market Overview by Therapeutic Area
  • 9.3. Rosetta Genomics (Israel) - A Major Market Player

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Biomarkers Market 2018 and 2025 by Geographic Region
  • Chart 2: Global Biomarkers Market 2018 and 2025 by Discovery Technology
  • Chart 3: Global Biomarkers Market 2018 and 2025 by Application
  • Chart 4: Global Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 5: Global Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 6: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
  • Chart 7: Global Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
  • Chart 8: Glance at 2016, 2019 and 2025 Global Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
  • Chart 9: Global Proteomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 10: Glance at 2016, 2019 and 2025 Global Proteomics for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 11: Global Genomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 12: Glance at 2016, 2019 and 2025 Global Genomics for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 13: Global Metabolomics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 14: Glance at 2016, 2019 and 2025 Global Metabolomics for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 15: Global Other Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 16: Glance at 2016, 2019 and 2025 Global Other Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 17: Global Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
  • Chart 18: Glance at 2016, 2019 and 2025 Global Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
  • Chart 19: Global MRI for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 20: Glance at 2016, 2019 and 2025 Global MRI for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 21: Global CT for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 22: Glance at 2016, 2019 and 2025 Global CT for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 23: Global Ultrasound for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 24: Glance at 2016, 2019 and 2025 Global Ultrasound for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 25: Global Other Bioimaging Modalities for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 26: Glance at 2016, 2019 and 2025 Global Other Bioimaging Modalities for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 27: Global Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 28: Glance at 2016, 2019 and 2025 Global Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 29: Global Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 30: Glance at 2016, 2019 and 2025 Global Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 31: Global Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 32: Glance at 2016, 2019 and 2025 Global Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 33: Global Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
  • Chart 34: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other
  • Chart 35: Global Biomarkers Market Analysis (2016-2025) in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 36: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 37: Global Biomarkers Market Analysis (2016-2025) in Cardiology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 38: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Cardiology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 39: Global Biomarkers Market Analysis (2016-2025) in Neurology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 40: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Neurology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 41: Global Biomarkers Market Analysis (2016-2025) in Other Therapeutic Areas by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 42: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) in Other Therapeutic Areas by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 43: Global Biomarkers Market Analysis (2016-2025) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in US$ Million
  • Chart 44: Glance at 2016, 2019 and 2025 Global Biomarkers Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 45: North American Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 46: North American Biomarkers Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in US$ Million
  • Chart 47: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 48: North American Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 49: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
  • Chart 50: North American Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
  • Chart 51: Glance at 2016, 2019 and 2025 North American Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
  • Chart 52: North American Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
  • Chart 53: Glance at 2016, 2019 and 2025 North American Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
  • Chart 54: North American Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 55: Glance at 2016, 2019 and 2025 North American Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 56: North American Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 57: Glance at 2016, 2019 and 2025 North American Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 58: North American Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 59: Glance at 2016, 2019 and 2025 North American Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 60: North American Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
  • Chart 61: Glance at 2016, 2019 and 2025 North American Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

The United States

  • Chart 62: United States Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 63: United States Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 64: Glance at 2016, 2019 and 2025 United States Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Canada

  • Chart 65: Canadian Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 66: Canadian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 67: Glance at 2016, 2019 and 2025 Canadian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Mexico

  • Chart 68: Mexican Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 69: Mexican Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 70: Glance at 2016, 2019 and 2025 Mexican Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

EUROPE

  • Chart 71: European Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 72: European Biomarkers Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in US$ Million
  • Chart 73: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
  • Chart 74: European Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 75: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
  • Chart 76: European Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
  • Chart 77: Glance at 2016, 2019 and 2025 European Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
  • Chart 78: European Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
  • Chart 79: Glance at 2016, 2019 and 2025 European Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
  • Chart 80: European Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
  • Chart 81: Glance at 2016, 2019 and 2025 European Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
  • Chart 82: European Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
  • Chart 83: Glance at 2016, 2019 and 2025 European Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
  • Chart 84: European Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe in USD Million
  • Chart 85: Glance at 2016, 2019 and 2025 European Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain, Sweden and Rest of Europe
  • Chart 86: European Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
  • Chart 87: Glance at 2016, 2019 and 2025 European Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

Germany

  • Chart 88: German Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 89: German Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 90: Glance at 2016, 2019 and 2025 German Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

The United Kingdom

  • Chart 91: United Kingdom Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 92: United Kingdom Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 93: Glance at 2016, 2019 and 2025 United Kingdom Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

France

  • Chart 94: French Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 95: French Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 96: Glance at 2016, 2019 and 2025 French Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Italy

  • Chart 97: Italian Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 98: Italian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 99: Glance at 2016, 2019 and 2025 Italian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Spain

  • Chart 100: Spanish Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 101: Spanish Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 102: Glance at 2016, 2019 and 2025 Spanish Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Sweden

  • Chart 103: Swedish Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 104: Swedish Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 105: Glance at 2016, 2019 and 2025 Swedish Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Rest of Europe

  • Chart 106: Rest of Europe Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 107: Rest of Europe Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 108: Glance at 2016, 2019 and 2025 Rest of Europe Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

ASIA-PACIFIC

  • Chart 109: Asia-Pacific Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 110: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in US$ Million
  • Chart 111: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
  • Chart 112: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 113: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
  • Chart 114: Asia-Pacific Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
  • Chart 115: Glance at 2016, 2019 and 2025 Asia-Pacific Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
  • Chart 116: Asia-Pacific Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
  • Chart 117: Glance at 2016, 2019 and 2025 Asia-Pacific Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
  • Chart 118: Asia-Pacific Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
  • Chart 119: Glance at 2016, 2019 and 2025 Asia-Pacific Omics Technologies for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
  • Chart 120: Asia-Pacific Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
  • Chart 121: Glance at 2016, 2019 and 2025 Asia-Pacific Bioimaging for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
  • Chart 122: Asia-Pacific Bioinformatics for Biomarkers Discovery Market Analysis (2016-2025) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific in USD Million
  • Chart 123: Glance at 2016, 2019 and 2025 Asia-Pacific Bioinformatics for Biomarkers Discovery Market Share (%) by Geographic Region - China, Japan, India, Australia and Rest of Asia-Pacific
  • Chart 124: Asia-Pacific Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
  • Chart 125: Glance at 2016, 2019 and 2025 Asia-Pacific Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

China

  • Chart 126: Chinese Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 127: Chinese Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 128: Glance at 2016, 2019 and 2025 Chinese Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Japan

  • Chart 129: Japanese Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 130: Japanese Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 131: Glance at 2016, 2019 and 2025 Japanese Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

India

  • Chart 132: Indian Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 133: Indian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 134: Glance at 2016, 2019 and 2025 Indian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Australia

  • Chart 135: Australian Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 136: Australian Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 137: Glance at 2016, 2019 and 2025 Australian Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

Rest of Asia-Pacific

  • Chart 138: Rest of Asia-Pacific Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 139: Rest of Asia-Pacific Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 140: Glance at 2016, 2019 and 2025 Rest of Asia-Pacific Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics

REST OF WORLD

  • Chart 141: Rest of World Biomarkers Market Analysis (2016-2025) in USD Million
  • Chart 142: Rest of World Biomarkers Market Analysis (2016-2025) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics in USD Million
  • Chart 143: Glance at 2016, 2019 and 2025 Rest of World Biomarkers Market Share (%) by Discovery Technology - Omics Technologies, Bioimaging and Bioinformatics
  • Chart 144: Rest of World Omics Technologies for Biomarkers Discovery Market Analysis (2016-2025) by Segment - Proteomics, Genomics, Metabolomics and Other in USD Million
  • Chart 145: Glance at 2016, 2019 and 2025 Rest of World Omics Technologies for Biomarkers Discovery Market Share (%) by Segment - Proteomics, Genomics, Metabolomics and Other
  • Chart 146: Rest of World Bioimaging for Biomarkers Discovery Market Analysis (2016-2025) by Modality - MRI, CT, Ultrasound and Other in USD Million
  • Chart 147: Glance at 2016, 2019 and 2025 Rest of World Bioimaging for Biomarkers Discovery Market Share (%) by Modality - MRI, CT, Ultrasound and Other
  • Chart 148: Rest of World Biomarkers Market Analysis (2016-2025) by Therapeutic Area - Oncology, Cardiology, Neurology and Other in USD Million
  • Chart 149: Glance at 2016, 2019 and 2025 Rest of World Biomarkers Market Share (%) by Therapeutic Area - Oncology, Cardiology, Neurology and Other

Tables:

  • Table 1: Biomarkers Role in Drug Discovery and Development Protocols
Back to Top